Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2021

Singh AK, Haque M, Madarampalli B, Shi Y, Wildman BJ, Basit A, et al. Ets-2 Propagates IL-6 Trans-Signaling Mediated Osteoclast-Like Changes in Human Rheumatoid Arthritis Synovial Fibroblast. Front Immunol. 2021;12:746503.

Velu P, Craney A, Ruggiero P, Sipley J, Cong L, Hissong EM, et al. Rapid Implementation of Severe Acute Respiratory Syndrome Coronavirus 2 Emergency Use Authorization RT-PCR Testing and Experience at an Academic Medical Institution. J Mol Diagn. 2021;23(2):149-158.

Magro CM, Mulvey J, Kubiak J, Mikhail S, Suster D, A Crowson N, et al. Severe COVID-19: A multifaceted viral vasculopathy syndrome. Ann Diagn Pathol. 2021;50:151645.

Stopsack KH, Tyekucheva S, Wang M, Gerke TA, J Vaselkiv B, Penney KL, et al. Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays. Elife. 2021;10.

Costa V, Zhao Z, Racine-Brzostek SE, Lalazar G, Yang HS. An Interesting Case of Isolated False-Reactive Hepatitis B Surface Antigen. Case Reports Hepatol. 2021;2021:9928098.

Wong R, Westerveld D, Yeo H, Jessurun J, Jesudian A. Ischemic Colitis From Idiopathic Myointimal Hyperplasia of the Mesenteric Veins in a Post-Liver Transplant Patient. ACG Case Rep J. 2021;8(11):e00692.

Oh H, Hwang I, Jang J-, Wu L, Cao D, Yao J, et al. Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling. Cancer Res. 2021;81(6):1528-1539.

Soshnev AA, C Allis D, Cesarman E, Melnick AM. Histone H1 mutations in lymphoma: a link(er) between chromatin organization, developmental reprogramming, and cancer. Cancer Res. 2021.

Mahale P, Nomburg J, Song JY, Steinberg M, Starrett G, Boland J, et al. Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma. Infect Agent Cancer. 2021;16(1):65.

Bégin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, et al. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Trials. 2021;22(1):323.